Application of trans-cassia twig acid in preparing drug for resisting bradyarrhythmia

A technology of trans-cinnamonic acid and arrhythmia, which can be used in drug combinations, cardiovascular system diseases, etc., can solve the problems of patients with bradyarrhythmias that cannot be effectively treated due to financial or technical reasons, and achieve a wide coverage of the disease and a good industry. The effect of chemical prospect and low cost

Inactive Publication Date: 2015-01-21
陈一江
1 Cites 0 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0011] The technical purpose of the present invention is to provide a bradyarrhythmia drug that can be used for long-term treatment, which can be used to replace ...
View more

Abstract

The invention discloses an application of trans-cassia twig acid in preparing a drug as shown in a formula I described in the specification for resisting bradyarrhythmia. The trans-cassia twig acid is relatively low in cost in comparison with the natural cassia twig acid, capable of being largely synthesized and produced and pushing the development of a traditional Chinese medicine preparation for resting bradycardia, and relatively good in industrial prospect.

Application Domain

Organic active ingredientsCardiovascular disorder

Technology Topic

DrugTraditional Chinese medicine +3

Image

  • Application of trans-cassia twig acid in preparing drug for resisting bradyarrhythmia
  • Application of trans-cassia twig acid in preparing drug for resisting bradyarrhythmia
  • Application of trans-cassia twig acid in preparing drug for resisting bradyarrhythmia

Examples

  • Experimental program(6)

Example Embodiment

[0058] Example 1: Effect of trans-cinnamonic acid on the heart rate of normal rats
[0059] Take 30 healthy rats, half male and half female, weighing 220±30g, and randomly divide them into: ①Cinnamic acid drug group, ②Blank group, ③Positive control group, 10 rats in each group, half male and half male. After one week of adaptive feeding in the experimental environment, the rats were generally in good condition, and gavage was started.
[0060] In the cinnamonic acid group, 50-250 mg/kg of trans-cinnamic acid was dissolved in 1-2-propanediol to prepare a saturated solution, which was administered by gavage continuously for 7 days. The positive control group was intraperitoneally injected with atropine 0.15 mg/kg;
[0061] 2 hours after the last gavage, the rats were weighed, and rats were anesthetized by intraperitoneal injection of 3% pentobarbital sodium 50 mg/kg. The supine position was fixed, and the needle electrodes were connected subcutaneously to the limbs. The electrocardiogram of the second lead of the rats was continuously monitored. The rat's heart rate was continuously recorded for 5 min.
[0062] Observation indicators: heart rate changes of rats before and after modeling.
[0063] Observation method Use the MedLab biological signal acquisition and processing system to detect the heart rate of rats, select "Experiment" - "Physiological Experiment" - "Animal ECG", magnification: 1000, upper limit frequency: 100, time constant: DC; record the experimental data;
[0064] Select "Online Measurement" - "ECG Measurement" to analyze the heart rate changes of rats.
[0065] Statistical processing: Input the rat heart rate data into the computer, and use SPSS19.0 Chinese version statistical software for statistical processing. data to Indicates that independent samples t-test and analysis of variance were used for comparison between groups; the results were statistically significant with P<0.01 or P<0.05. The results are shown in Table 1:
[0066] Table 1: Comparison of the heart rate of rats in the cinnamic acid group and the blank group
[0067]
[0068] t-test: △Comparison of heart rate between blank group and cinnamomilic acid drug control group: △P<0.01; ▲Comparison of heart rate between Atr control group and blank group: ▲P<0.01
[0069] Conclusion: Cinnamominic acid can increase the heart rate of normal rats. Atropine was used as the positive control group.

Example Embodiment

[0070] Example 2: Effect of trans-cinnamic acid on the heart rate of rats with acetylcholine-induced bradycardia
[0071] 30 healthy rats, half male and half female, weighing 220±30g, were randomly divided into: ① cinnamic acid group, ② acetylcholine model group, 10 rats in each group, half male and half male. After one week of adaptive feeding in the experimental environment, the rats were generally in good condition, and gavage was started.
[0072] In the cinnamonic acid group, 50-250 mg/kg of trans-cinnamic acid was dissolved in 1-2-propanediol to prepare a saturated solution, which was administered by gavage continuously for 7 days. The saline group was intragastrically administered for 7 days, and the positive control group was intraperitoneally injected with atropine 0.15 mg/kg;
[0073] 2 hours after the last gavage, the rats were weighed, and rats were anesthetized by intraperitoneal injection of 3% pentobarbital sodium 50 mg/kg. The supine position was fixed, and the needle electrodes were connected subcutaneously to the limbs. The electrocardiogram of the second lead of the rats was continuously monitored. Rats were injected with 0.1% acetylcholine chloride 2ml/kg into the tail vein to establish the model, and the heart rate of the rat was continuously recorded for 30 minutes, and the heart rate was recorded at 5 minutes, 10 minutes, 20 minutes and 30 minutes after the injection; observation index: the heart rate change of the rat before and after the model was established.
[0074] Observation method Use the MedLab biological signal acquisition and processing system to detect the heart rate of rats, select "Experiment" - "Physiological Experiment" - "Animal ECG", magnification: 1000, upper limit frequency: 100, time constant: DC; record the experimental data;
[0075] Select "Online Measurement" - "ECG Measurement" to analyze the heart rate changes of rats.
[0076] Statistical processing: Input the rat heart rate data into the computer, and use SPSS19.0 Chinese version statistical software for statistical processing. data to Indicates that independent samples t-test and analysis of variance were used for comparison between groups; the results were statistically significant with P<0.01 or P<0.05. The results are shown in Table 2:
[0077] Table 2: Comparison of heart rate before and after modeling in each group of acetylcholine model
[0078]
[0079] t-test: Comparison of heart rate decline between the 30min ach model group and the cinnamic acid group: ▲P<0.05
[0080] Conclusion: After successful modeling with acetylcholine, the decrease in heart rate between the cinnamonic acid group and the acetylcholine model group at 30 minutes was P<0.05, and the rate of heart rate decrease in the cinnamonic acid group was smaller than that in the model group after 30 minutes, and there was a statistical difference.
[0081] Trans-cinnamic acid has the effect of resisting the bradyarrhythmia of the acetylcholine rat model, and can increase the heart rate of the rat model. Example 3: Effect of trans-cinnamic acid on the heart rate of rats with bradycardia induced by verapamil

Example Embodiment

[0081] Trans-cinnamic acid has the effect of resisting the bradyarrhythmia of the acetylcholine rat model, and can increase the heart rate of the rat model. Example 3: Effect of trans-cinnamic acid on the heart rate of rats with bradycardia induced by verapamil
[0082] Take 30 healthy rats, half male and half female, weighing 220±30g, and randomly divide them into: ① cinnamic acid group, ② verapamil model group, ③ positive control group, 10 rats in each group, half male and half male. After one week of adaptive feeding in the experimental environment, the rats were generally in good condition, and gavage was started.
[0083] In the cinnamonic acid group, 50-250 mg/kg of trans-cinnamic acid was dissolved in 1-2-propanediol to prepare a saturated solution, which was administered by gavage continuously for 7 days. The equal-volume normal saline group was given continuous intragastric administration for 7 days, and the positive control group was intraperitoneally injected with atropine 0.15 mg/kg;
[0084] 2 hours after the last gavage, the rats were weighed, anesthetized by intraperitoneal injection of 3% pentobarbital sodium 50 mg/kg, fixed in the supine position, needle electrodes were connected subcutaneously to the limbs, and the electrocardiogram of lead II of the rats was continuously monitored. After the heart rate was stable, Rats were injected with verapamil injection 5 mg/kg into the tail vein to establish a model, and the heart rate was recorded at 3 minutes, 5 minutes, 10 minutes, 20 minutes and 30 minutes after the injection;
[0085] Observation indicators: heart rate changes of rats before and after modeling.
[0086] Observation method Use the MedLab biological signal acquisition and processing system to detect the heart rate of rats, select "Experiment" - "Physiological Experiment" - "Animal Electrocardiogram", magnification: 1000, upper limit frequency: 100, time constant: DC; record the experimental data;
[0087] Select "Online Measurement" - "ECG Measurement" to analyze the heart rate changes of rats.
[0088] Statistical processing: Input the rat heart rate data into the computer, and use SPSS19.0 Chinese version statistical software for statistical processing. data to Indicates that independent samples t-test and analysis of variance were used for comparison between groups; the results were statistically significant with P<0.01 or P<0.05. The results are shown in Table 3:
[0089] Table 3: Comparison of heart rate before and after modeling in each group of verapamil model
[0090]
[0091] t-test: Comparison of heart rate decline between the 30min ver model group and the cinnamonylic acid group: ▲P<0.05
[0092]Conclusion: After successful modeling with verapamil, the decrease in heart rate between the cinnamonic acid group and the acetylcholine model group at 30 minutes was P<0.05.
[0093] Trans-cinnamic acid has the effect of resisting the bradyarrhythmia of the verapamil rat model, and can increase the heart rate of the rat model.

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Apparatus and method for low-density cellular wood plastic composites

InactiveUS20050067729A1less-expensivelow cost
Owner:STRANDEX CORP

Haptic trackball device

InactiveUS7710399B2simple actuatorlow cost
Owner:IMMERSION CORPORATION

Steering Arrangement for a Trailer

InactiveUS20110018231A1low cost
Owner:ZF FRIEDRICHSHAFEN AG

Classification and recommendation of technical efficacy words

  • Good prospects for industrialization
  • low cost

Method for preparing large-area perovskite solar cell based on spraying technology

InactiveCN105655489AEasy to prepareGood prospects for industrialization
Owner:MATERIAL INST OF CHINA ACADEMY OF ENG PHYSICS

Synthesis of tulathromycin

PendingCN113861252Ashort reaction timeGood prospects for industrialization
Owner:江苏君若药业有限公司

System and method for transmitting wireless digital service signals via power transmission lines

ActiveUS7929940B1reduce bandwidth requirementlow cost
Owner:NEXTEL COMMUNICATIONS

System and method for determination of position

InactiveUS20090149202A1low costreduce requirement
Owner:STEELE CHRISTIAN

Adaptive antenna optimization network

InactiveUS6961368B2low costminimal space
Owner:ERICSSON INC

Antenna device and method for attaching the same

ActiveUS20150138022A1low costimproved strength characteristic
Owner:NEC CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products